• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Drug Seizures In Frankfurt Spark Fears Of EU-Wide Pattern

05/06/2009 by Kaitlin Mara for Intellectual Property Watch 8 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Health advocates have raised alarm over reports that several million pills of generic medicine were held up in Frankfurt airport in May despite being destined for a different port. And new information has come to light indicating Dutch seizures were more numerous than originally thought. These developments have prompted outcry and the assertion that a European-wide law on customs and intellectual property is problematic.

There were 17 cases of medicine seizure in 2008, said Sophie Bloemen of Health Action International, quoting a response of the Dutch authorities to an HAI freedom of information request (Wet Openbaar Bestuur in Dutch). Concerns have risen in recent months over delayed shipments of legal generic medicines passing through the Netherlands from India (IPW, Enforcement, 6 March 2009). The issue could come up at the World Trade Organization Council on Trade-Related Aspects of Intellectual Property Rights, meeting 8-9 June, as it has in the past (IPW, WTO, 3 February 2009).

The Frankfurt seizure is the first reported in Germany under the European Community regulation 1383/2003 [doc], which provides rules and regulations over the authority of customs officers to control goods believed to be infringing IP rights. The latest seizure has escalated calls for a change in the regulation.

An Indian official raised concern to Intellectual Property Watch Friday about “a pattern” of delaying generics, which the official said indicates a “well-thought out strategy” on the part of IP enforcement authorities.

‘’These random seizures seriously impact our ability to service the healthcare needs of people living in developing countries in a timely manner, forcing us to consider re-designing our entire supply chain to avoid any transit through European territories,” said Sune Sveningsen of Missionpharma, which had supplied the drugs stopped in Germany.

She was quoted in a 5 June press release [pdf] signed by five non-governmental organisations working in public health advocacy: Health Action International, the Third World Network, Medico International, BUKO Pharma-Kampagne and Oxfam Germany.

17 Dutch Seizures

Of the 17 Dutch seizures, 16 were shipped from India and one from China, according to the response of the Dutch government to HAI’s freedom of information request. The Netherlands was not the final destination of any of these shipments. They were instead headed to ports in Peru, Columbia, Ecuador, Mexico, Portugal, Spain, Brazil and Nigeria.

They contained medications related to cardiology, lifestyle, HIV/AIDS, dementia, and schizophrenia, according to a translation of the response by Bloemen. Of these, six “assumed permission” to destroy, which Bloemen said means the generic manufacturer did not react to the rights holder. A copy of the letter from the Dutch government is available here [pdf], but in Dutch only. A translation into English is expected to be posted to the HAI website soon, she said.

Challenging the EU Regulation

“Patent infringement” should be excluded from the EU regulation 1383/2003 “in order to avoid seizures of legitimate generic medicines in transit,” Alexandra Heumber, IP policy adviser to the Médecins Sans Frontières (MSF) Access to Essential Medicines Campaign, told Intellectual Property Watch.

The law that 1383/2003 grew out of, a 1994 regulation 3295/94, was much narrower in scope, she explained. Rather than including all violations of intellectual property, it focussed on counterfeit and pirated goods – generally a trademark issue.

The updated, broader law, is problematic as “we have seen no justification for the extension to this area and no impact assessment of the effects,” she added.

The German Seizure

According to the advocates, the German seizure also shipped from India. Over 3 million pills of Amoxicillin, a generic antibiotic, were stopped in Frankfurt airport on 5 May on the suspicion that they had infringed a brand-name antibiotic, Amoxil, owned by GlaxoSmithKline (GSK).

There is “no valid reason for detaining these medicines,” said the press release. German authorities could not be reached by press time.

GSK, when contacted by authorities, said that there had been no infringement, the press release said. This allowed the medicines to be released to their destination, the island country Vanuatu.

The pills contained in the shipment represent 76,000 courses of treatment, which were delayed by 4 weeks in their journey to the Pacific, according to the press release.

“The EC should urgently provide clear guidance to the customs in order to avoid detainment of legitimate generic medicine in transit,” Heumber said. “Those detainments have an impact on the access to medicines for patients in developing countries.”

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Kaitlin Mara may be reached at kmara@ip-watch.ch.

Creative Commons License"Drug Seizures In Frankfurt Spark Fears Of EU-Wide Pattern" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, News, Themes, Venues, Copyright Policy, Enforcement, English, Europe, Health & IP, Patents/Designs/Trade Secrets, WTO/TRIPS

Comments

  1. Cathy says

    25/09/2009 at 8:56 pm

    Did the letter from the Dutch Authorities mentioned above ever get translated to English? If so, can someone provide me with the link.

    Reply
  2. Kaitlin Mara says

    25/09/2009 at 9:13 pm

    Hi Cathy,

    Yes, Health Action International had it translated. You can find the English version (in PDF format) by clicking here.

    Reply

Trackbacks

  1. Enlarging the ‘territorial’ nature of IP rights for goods in transit « says:
    17/06/2009 at 6:19 pm

    […] 17, 2009 · No Comments An article recently posted on IP Watch provokes a rather interesting discussion regarding the way IP rights have been enforced on goods […]

    Reply
  2. JOLT Digest » Flash Digest: News in Brief | Harvard Journal of Law & Technology says:
    20/06/2009 at 6:28 pm

    […] to a recent report by Intellectual Property Watch, an increase in European seizures of Indian medicines believed to […]

    Reply
  3. Unpacking Development » Blog Archive » European Drug Pirates: Seizure of Generic Drugs a Growing Trend says:
    01/07/2009 at 5:35 am

    […] World at York University, its possible to draw parallels between recent drug seizures (17 in Holland in 2008 alone) in Europe and the havoc being wrought by Somali pirates in the Indian […]

    Reply
  4. FFII: EU ‘Trade’ Agreement an Attack on Free Software Developers | Boycott Novell says:
    12/01/2010 at 4:28 am

    […] EU seizures of life saving medicine meant for developing countries […]

    Reply
  5. Minister: India Anticipates European Fix To Law Delaying Generics Shipments | Intellectual Property Watch says:
    30/07/2011 at 9:25 am

    […] Europe has promised at the “highest levels” to fix laws that caused generic medicine seizures in the Netherlands, the Indian Minister of Commerce and Industry said today. The minister is in Geneva for meetings on the ongoing Doha Round trade liberalisation talks at the World Trade Organization. “The actions that were taken were not only TRIPS plus but TRIPS illegal,” Minister Anand Sharma told journalists at the WTO, referring to the 1994 WTO Trade-Related Aspects of Intellectual Property Rights agreement, as well as to delays in generic drug shipments in 2008 (IPW, WHO, 5 June 2009) […]

    Reply
  6. New EU Custom Regulation Might Allow Wrongful Seizures Of Generic Drugs In Transit, NGOs Say | Intellectual Property Watch says:
    17/10/2013 at 2:14 pm

    […] property rights infringement. Some 17 shipments were detained, 16 from India and 1 from China (IPW, Public Health, 5 June 2009). The medicines were not patented in the source or destination countries, and were supposed to be […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.